Ebit 更改
3i Infrastructure GBP 280M 101M 2025-12
AstraZeneca USD 3.16B 3.95B 2026-06
GlaxoSmithKline GBP 2.29B 856M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12